Composition

Active ingredient: Ceftriaxone (as the disodium salt).

EPICEPHIN contains approximately 83 mg (3.6 mEq) of sodium per gram of ceftriaxone.

EPICEPHIN 500 mg IM Vials:
Each vial contains:
Ceftriaxone (as disodium ceftriaxone) ..................
500 mg
Solvent: Lidocaine hydrochloride 20 mg, water q.s.
2 ml of solution.

EPICEPHIN 500 mg IV Vials:
Each vial contains:
Ceftriaxone (as disodium ceftriaxone) ...................
500 mg
Solvent: Water for injection 5 ml.

EPICEPHIN 1 g IM Vials:
Each vial contains:
Ceftriaxone (as disodium ceftriaxone) ...................
1 g
Solvent: Lidocaine hydrochloride 35 mg, water q.s.
3.5 ml of solution.

EPICEPHIN 1 g IV Vials:
Each vial contains:
Ceftriaxone (as disodium ceftriaxone) ....................
1 g
Solvent: Water for injection 10 ml.

EPICEPHIN 2 g IV Vials:
Each vial contains:
Ceftriaxone (as disodium ceftriaxone) ....................
2 g

Therapeutic Indications

Infections caused by pathogens which are susceptible to ceftriaxone e.g.:
Respiratory tract infections, particularly pneumonia, and ear, nose and throat infections.
Abdominal infections (peritonitis, infections of the biliary and gastrointestinal tracts).
Renal and urinary tract infections.
Infections of the genital organs, including gonorrhoea.
Sepsis.
Infections of the bones, joints, soft tissue and skin, and wound infections.
Infections in patients with impaired immune response.
Meningitis.
Disseminated Lyme borreliosis (stages II and III).

Perioperative prophylaxis of infections in operations on the gastrointestinal tract, biliary tract and urogenital tract and in gynecological procedures, but only in cases of potential or known contamination.

Official recommendations on appropriate use of antibiotics should be observed, in particular recommendations on how to prevent increased antibiotic resistance.